NCT04132479View on ClinicalTrials.gov

The Epidemiology and Optimal Treatment of Helicobacter Pylori in Myanmar

PHASE4CompletedINTERVENTIONAL
Enrollment

313

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

December 31, 2018

Study Completion Date

April 9, 2019

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Clarithromycin 500mg

1000mg taken orally every 12 hours for 5 days

DRUG

Amoxicillin 500mg

1000mg taken orally every 12 hours for 5 days

DRUG

Tinidazole 500mg

500mg taken orally every 12 hours for 5 days

DRUG

Rabeprazole 20mg

20mg taken orally every 12 hours for 5 days

DRUG

Clarithromycin 500mg

1000mg taken orally every 12 hours for 14 days

DRUG

Amoxicillin 500mg

1000mg taken orally every 12 hours for 14 days

DRUG

Tinidazole 500mg

500mg taken orally every 12 hours for 14 days

DRUG

Rabeprazole 20mg

20mg taken orally every 12 hours for 14 days

Trial Locations (1)

11011

Insein General Hospital, Yangon

Sponsors

Lead Sponsor

Kirby Institute
All Listed Sponsors
collaborator

University of Medicine 2, Yangon, Myanmar

UNKNOWN

lead

Kirby Institute

OTHER_GOV

NCT04132479 - The Epidemiology and Optimal Treatment of Helicobacter Pylori in Myanmar | Biotech Hunter | Biotech Hunter